Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

319 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Current clinical management of CIDP with immunoglobulins in France: An expert opinion.
Cintas P, Bouhour F, Cauquil C, Masingue M, Tard C, Sacconi S, Delmont E, Choumert A, Chanson JB, Michaud M, Solé G, Cassereau J, Noury JB, Nicolas G, Bellance R, Péréon Y, Camdessanché JP, Magy L, Attarian S; French Neuromuscular diseases network (Filnemus). Cintas P, et al. Among authors: sole g. Rev Neurol (Paris). 2023 Oct;179(8):914-922. doi: 10.1016/j.neurol.2023.03.010. Epub 2023 Apr 3. Rev Neurol (Paris). 2023. PMID: 37019741 Free article.
Clinical features and maternal and fetal outcomes in women with Guillain-Barré syndrome in pregnancy.
Krief N, Gabriel R, Cauquil C, Adams D, Fargeot G, Maisonobe T, Osman D, Schmidt M, Chanson JB, Bigaut K, Sole G, Tard C, Nicolas G, Pereon Y, Aure K, Lagrange E, Lefilliatre M, Labeyrie MA, Echaniz-Laguna A. Krief N, et al. Among authors: sole g. J Neurol. 2023 Sep;270(9):4498-4506. doi: 10.1007/s00415-023-11808-w. Epub 2023 Jun 9. J Neurol. 2023. PMID: 37294323 Free PMC article.
Clinical Neurology in Practice: The Tongue (part 2).
Mathis S, Solé G, Damon-Perrière N, Rouanet-Larrivière M, Duval F, Prigent J, Nadal L, Péréon Y, Le Masson G. Mathis S, et al. Among authors: sole g. Neurologist. 2024 Jan 1;29(1):59-69. doi: 10.1097/NRL.0000000000000510. Neurologist. 2024. PMID: 37639532
Clinical Neurology in Practice: The Tongue (Part 1).
Mathis S, Solé G, Damon-Perrière N, Rouanet-Larrivière M, Duval F, Prigent J, Nadal L, Péréon Y, Le Masson G. Mathis S, et al. Among authors: sole g. Neurologist. 2023 Sep 1;28(5):338-348. doi: 10.1097/NRL.0000000000000512. Neurologist. 2023. PMID: 37639535 Review.
Titin copy number variations associated with dominant inherited phenotypes.
Perrin A, Métay C, Savarese M, Ben Yaou R, Demidov G, Nelson I, Solé G, Péréon Y, Bertini ES, Fattori F, D'Amico A, Ricci F, Ginsberg M, Seferian A, Boespflug-Tanguy O, Servais L, Chapon F, Lagrange E, Gaudon K, Bloch A, Ghanem R, Guyant-Maréchal L, Johari M, Van Goethem C, Fardeau M, Morales RJ, Genetti CA, Marttila M, Koenig M, Beggs AH, Udd B, Bonne G, Cossée M. Perrin A, et al. Among authors: sole g. J Med Genet. 2024 Mar 21;61(4):369-377. doi: 10.1136/jmg-2023-109473. J Med Genet. 2024. PMID: 37935568
Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study.
Bril V, Drużdż A, Grosskreutz J, Habib AA, Mantegazza R, Sacconi S, Utsugisawa K, Vissing J, Vu T, Boehnlein M, Bozorg A, Gayfieva M, Greve B, Woltering F, Kaminski HJ; MG0003 study team. Bril V, et al. Lancet Neurol. 2023 May;22(5):383-394. doi: 10.1016/S1474-4422(23)00077-7. Lancet Neurol. 2023. PMID: 37059507 Clinical Trial.
Safety of immune checkpoint inhibitor rechallenge after severe immune-related adverse events: a retrospective analysis.
Eldani C, Kostine M, Faure M, Lazaro E, Rigothier C, Hiriart JB, Teulières B, Poullenot F, Haissaguerre M, Zysman M, Veillon R, Vergnenegre C, Issa N, Domblides C, Mary-Prey S, Beylot-Barry M, Pham-Ledard A, Dutriaux C, Sole G, Duval F, Gerard E. Eldani C, et al. Among authors: sole g. Front Oncol. 2024 Jul 8;14:1403658. doi: 10.3389/fonc.2024.1403658. eCollection 2024. Front Oncol. 2024. PMID: 39040444 Free PMC article.
319 results